NCT03403504View on ClinicalTrials.gov

OTR Tablet 10 mg Fasted-state Bioequivalence Study

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

February 1, 2017

Primary Completion Date

July 24, 2017

Study Completion Date

September 7, 2017

Conditions
Chronic Pain
Interventions
DRUG

Oxycodone Tamper Resistant

Orally administered Oxycodone Tamper Resistant 10mg

DRUG

OXYCONTIN®

Orally administered OXYCONTIN® Tablet 10 mg

Trial Locations (1)

Unknown

The Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Shenyang

All Listed Sponsors
lead

Mundipharma (China) Pharmaceutical Co. Ltd

INDUSTRY

NCT03403504 - OTR Tablet 10 mg Fasted-state Bioequivalence Study | Biotech Hunter | Biotech Hunter